DuPont de Nemours stock
DDNYSEDuPont de Nemours, Inc., Basic MaterialsISIN US26614N2018
50Score 50 out of 100, Neutral
Price and trend
67 / 100
Price history
+28% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 12% above it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 75).
The price is at its 52-week high. Largest decline in 20 years: 87% (July 2007 to March 2009).
Chart figures for advanced users
- SMA 50$134.48
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$139.23
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)75
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$111.36
- The lowest closing price of the last twelve months.
- Resistance$156.88
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- DuPont de Nemours, Inc. belongs to the Chemicals industry (United States) and, with a market value of $20.62B, is number 6 of 44 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $6.85B (down 44.7% year on year) and a loss of $779M.
- For fiscal 2026, analysts expect on average revenue of $7.18B (up 4.9%) and adjusted earnings per share of $7.44.
Show more
- MEQIRI Score 50 out of 100 (Neutral): rank 326 of 467 in Basic Materials, median 58.
- The P/E is 54.2 (Chemicals median 15.6, own median of recent years 10.9).
- Our model puts fair value at $108.76, with the price 43% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Share buybacksShare count down 43% since 2020.
Weaknesses
- Richly valuedP/E 54.2, Chemicals median 15.6, own median 10.9.Valuation 27
- Interest barely coveredOperating profit covers interest only 1.6 times.Stability 69
Its standout strength is momentum, while growth and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among stocks ranked 101 to 1,000.
From 2016 to 2025, 13 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
- weak fundamentals
What lowers it
- price near its 52-week high
Valuation
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $77.69 and expensive above $181.27 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $172.70 (cash-flow model) and $44.83 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $94.08, at 7.8% it would be $130.81.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (15.6).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the quarter to 30 Sep 2026, revenue fell 39.2% on the same quarter a year earlier. Up to 2024 the bars include businesses that were later spun off or sold. On a comparable basis, as restated in the SEC annual reports, revenue grew 2.3% a year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 30%, operating 13%, net not measured.
Debt & balance sheet
latest quarterDebt is low, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 9 Feb 2027in 89 days
- Last reported
- 3 Nov 2026EPS reported $2.09 (expected $1.87)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $7.44+2.5%
- Revenue
- $7.18B+0.2%
- Earnings per share
- $8.16+2.1%
- Revenue
- $7.49B+0.5%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +4.3%2026 guidance raised again: organic growth slightly above 4%, adjusted EPS midpoint of $7.24 (up $0.15), and free cash flow conversion above the 90% target.
“For the full year 2026, our net sales guidance now assumes organic growth to be slightly ahead of 4% on continued strength across most of our key end markets. We have adjusted our midpoint to $7.175 billion due to a lower expected currency benefit as the U.S. dollar continues to strengthen.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 4 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 3 insiders sold, $14.15M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Hoover Erik T.Sale
9 Nov 2026, SVP & General Counsel
- Shares
- 4,203
- Price
- $150.82
- Value
- $633,896
- Koch LoriSale
9 Nov 2026, CEO
- Shares
- 2,311
- Price
- $151.15
- Value
- $349,308
- Breen Edward DSale
5 Nov 2026, Board
- Shares
- 89,845
- Price
- $146.41
- Value
- $13.15M
Show 1 more
- Koch LoriSale
2 Jun 2026, CEO
- Shares
- 260.98
- Price
- $48.82
- Value
- $12,741
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at DuPont de Nemours
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 50
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals
The next larger and next smaller companies by market value
- Shin-Etsu Chemical4063.T $65.1B72
- BASFBAS.DE $52.27B54
- DowDOW $23.56B43
- Ningxia Baofeng Energy Group600989.SS $23.06B74
- Rongsheng Petrochemical002493.SZ $17.48B52
- Hengli Petrochemical600346.SS $17.34B50
- Zangge Mining000408.SZ $15.41B72
- Resonac Holdings4004.T $14.99B45
ETFs that hold DuPont de Nemours
Held by 97 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Amundi Global Gender Equality UCITS ETF AccVOOM | 0.70% | 0.20% | €55.72M |
| Invesco S&P 500 QVM UCITS ETFQVMP | 0.43% | 0.35% | €50.82M |
| State Street SPDR S&P U.S. Industrials Select Sector UCITS ETF (Acc)ZPDI | 0.38% | 0.15% | €874.42M |
Show 5 more
| iShares S&P 500 Industrials Sector UCITS ETF2B7C | 0.38% | 0.15% | €635.94M |
| iShares MSCI USA Mid-Cap Equal Weight UCITS ETFQDVC | 0.35% | 0.20% | €268.74M |
| Xtrackers S&P 500 Equal Weight UCITS ETF 1CXDEW | 0.24% | 0.15% | €14.88B |
| Deka MSCI USA MC UCITS ETFEL41 | 0.23% | 0.30% | €51.58M |
| Xtrackers MSCI World Industrials UCITS ETF 1CXDWI | 0.21% | 0.25% | €1.21B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 10 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.